National Drug Scheduling Advisory Committee issues interim recommendations on drug schedule status change for loratadine products used in children two to 11 years of age.
Adrian Dix said in January that the government would be investigating why almost 10% of prescriptions for the drug in B.C. were filled for American citizens.